nodes	percent_of_prediction	percent_of_DWPC	metapath
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Vismodegib—skin cancer	0.00854	0.00854	CcSEcCtD
Zanamivir—Face oedema—Imiquimod—skin cancer	0.00853	0.00853	CcSEcCtD
Zanamivir—Skin disorder—Vismodegib—skin cancer	0.00801	0.00801	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.00792	0.00792	CcSEcCtD
Zanamivir—Influenza—Imiquimod—skin cancer	0.00764	0.00764	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00751	0.00751	CcSEcCtD
Zanamivir—Musculoskeletal pain—Temozolomide—skin cancer	0.00738	0.00738	CcSEcCtD
Zanamivir—Bronchitis—Imiquimod—skin cancer	0.00735	0.00735	CcSEcCtD
Zanamivir—Decreased appetite—Vismodegib—skin cancer	0.00717	0.00717	CcSEcCtD
Zanamivir—Fatigue—Vismodegib—skin cancer	0.00711	0.00711	CcSEcCtD
Zanamivir—Influenza like illness—Temozolomide—skin cancer	0.00708	0.00708	CcSEcCtD
Zanamivir—Pain—Vismodegib—skin cancer	0.00705	0.00705	CcSEcCtD
Zanamivir—Erythema multiforme—Vemurafenib—skin cancer	0.00678	0.00678	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.00675	0.00675	CcSEcCtD
Zanamivir—Gastrointestinal pain—Vismodegib—skin cancer	0.00674	0.00674	CcSEcCtD
Zanamivir—Abdominal pain—Vismodegib—skin cancer	0.00652	0.00652	CcSEcCtD
Zanamivir—Chills—Vemurafenib—skin cancer	0.00643	0.00643	CcSEcCtD
Zanamivir—Sinusitis—Imiquimod—skin cancer	0.00639	0.00639	CcSEcCtD
Zanamivir—Ear pain—Temozolomide—skin cancer	0.00621	0.00621	CcSEcCtD
Zanamivir—Haemoglobin—Imiquimod—skin cancer	0.00614	0.00614	CcSEcCtD
Zanamivir—Haemorrhage—Imiquimod—skin cancer	0.00611	0.00611	CcSEcCtD
Zanamivir—Asthenia—Vismodegib—skin cancer	0.00591	0.00591	CcSEcCtD
Zanamivir—Erythema multiforme—Imiquimod—skin cancer	0.00578	0.00578	CcSEcCtD
Zanamivir—Diarrhoea—Vismodegib—skin cancer	0.00564	0.00564	CcSEcCtD
Zanamivir—Chills—Imiquimod—skin cancer	0.00549	0.00549	CcSEcCtD
Zanamivir—Arrhythmia—Imiquimod—skin cancer	0.00546	0.00546	CcSEcCtD
Zanamivir—Cough—Vemurafenib—skin cancer	0.00545	0.00545	CcSEcCtD
Zanamivir—Bronchospasm—Bleomycin—skin cancer	0.00534	0.00534	CcSEcCtD
Zanamivir—Arthralgia—Vemurafenib—skin cancer	0.00531	0.00531	CcSEcCtD
Zanamivir—Myalgia—Vemurafenib—skin cancer	0.00531	0.00531	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.00528	0.00528	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Dactinomycin—skin cancer	0.00527	0.00527	CcSEcCtD
Zanamivir—Vomiting—Vismodegib—skin cancer	0.00524	0.00524	CcSEcCtD
Zanamivir—Rash—Vismodegib—skin cancer	0.0052	0.0052	CcSEcCtD
Zanamivir—Dermatitis—Vismodegib—skin cancer	0.00519	0.00519	CcSEcCtD
Zanamivir—Face oedema—Temozolomide—skin cancer	0.00511	0.00511	CcSEcCtD
Zanamivir—Anaphylactic shock—Vemurafenib—skin cancer	0.00509	0.00509	CcSEcCtD
Zanamivir—Infection—Vemurafenib—skin cancer	0.00506	0.00506	CcSEcCtD
Zanamivir—Skin disorder—Vemurafenib—skin cancer	0.00495	0.00495	CcSEcCtD
Zanamivir—Ill-defined disorder—Imiquimod—skin cancer	0.00494	0.00494	CcSEcCtD
Zanamivir—Dehydration—Temozolomide—skin cancer	0.00492	0.00492	CcSEcCtD
Zanamivir—Nausea—Vismodegib—skin cancer	0.0049	0.0049	CcSEcCtD
Zanamivir—Agitation—Imiquimod—skin cancer	0.00489	0.00489	CcSEcCtD
Zanamivir—Malaise—Imiquimod—skin cancer	0.0048	0.0048	CcSEcCtD
Zanamivir—Syncope—Imiquimod—skin cancer	0.00477	0.00477	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.00477	0.00477	CcSEcCtD
Zanamivir—Neutropenia—Dactinomycin—skin cancer	0.00473	0.00473	CcSEcCtD
Zanamivir—Influenza like illness—Docetaxel—skin cancer	0.00471	0.00471	CcSEcCtD
Zanamivir—Loss of consciousness—Imiquimod—skin cancer	0.00468	0.00468	CcSEcCtD
Zanamivir—Cough—Imiquimod—skin cancer	0.00464	0.00464	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00464	0.00464	CcSEcCtD
Zanamivir—Convulsion—Imiquimod—skin cancer	0.00461	0.00461	CcSEcCtD
Zanamivir—Arthralgia—Imiquimod—skin cancer	0.00453	0.00453	CcSEcCtD
Zanamivir—Myalgia—Imiquimod—skin cancer	0.00453	0.00453	CcSEcCtD
Zanamivir—Anxiety—Imiquimod—skin cancer	0.00451	0.00451	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.0045	0.0045	CcSEcCtD
Zanamivir—Discomfort—Imiquimod—skin cancer	0.00448	0.00448	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.00447	0.00447	CcSEcCtD
Zanamivir—Decreased appetite—Vemurafenib—skin cancer	0.00443	0.00443	CcSEcCtD
Zanamivir—Bronchitis—Temozolomide—skin cancer	0.0044	0.0044	CcSEcCtD
Zanamivir—Fatigue—Vemurafenib—skin cancer	0.00439	0.00439	CcSEcCtD
Zanamivir—Haemoglobin—Bleomycin—skin cancer	0.00437	0.00437	CcSEcCtD
Zanamivir—Haemorrhage—Bleomycin—skin cancer	0.00434	0.00434	CcSEcCtD
Zanamivir—Infection—Imiquimod—skin cancer	0.00431	0.00431	CcSEcCtD
Zanamivir—Neutropenia—Temozolomide—skin cancer	0.00428	0.00428	CcSEcCtD
Zanamivir—Shock—Imiquimod—skin cancer	0.00427	0.00427	CcSEcCtD
Zanamivir—Skin disorder—Imiquimod—skin cancer	0.00422	0.00422	CcSEcCtD
Zanamivir—Anorexia—Imiquimod—skin cancer	0.00414	0.00414	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.00405	0.00405	CcSEcCtD
Zanamivir—Body temperature increased—Vemurafenib—skin cancer	0.00403	0.00403	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00396	0.00396	CcSEcCtD
Zanamivir—Chills—Bleomycin—skin cancer	0.0039	0.0039	CcSEcCtD
Zanamivir—Dyspnoea—Imiquimod—skin cancer	0.00387	0.00387	CcSEcCtD
Zanamivir—Erythema multiforme—Dactinomycin—skin cancer	0.00383	0.00383	CcSEcCtD
Zanamivir—Sinusitis—Temozolomide—skin cancer	0.00383	0.00383	CcSEcCtD
Zanamivir—Decreased appetite—Imiquimod—skin cancer	0.00378	0.00378	CcSEcCtD
Zanamivir—Hypersensitivity—Vemurafenib—skin cancer	0.00375	0.00375	CcSEcCtD
Zanamivir—Fatigue—Imiquimod—skin cancer	0.00374	0.00374	CcSEcCtD
Zanamivir—Pain—Imiquimod—skin cancer	0.00371	0.00371	CcSEcCtD
Zanamivir—Haemoglobin—Temozolomide—skin cancer	0.00368	0.00368	CcSEcCtD
Zanamivir—Haemorrhage—Temozolomide—skin cancer	0.00366	0.00366	CcSEcCtD
Zanamivir—Asthenia—Vemurafenib—skin cancer	0.00365	0.00365	CcSEcCtD
Zanamivir—Hallucination—Temozolomide—skin cancer	0.00365	0.00365	CcSEcCtD
Zanamivir—Chills—Dactinomycin—skin cancer	0.00363	0.00363	CcSEcCtD
Zanamivir—Feeling abnormal—Imiquimod—skin cancer	0.00358	0.00358	CcSEcCtD
Zanamivir—Gastrointestinal pain—Imiquimod—skin cancer	0.00355	0.00355	CcSEcCtD
Zanamivir—Sinusitis—Fluorouracil—skin cancer	0.00353	0.00353	CcSEcCtD
Zanamivir—Ill-defined disorder—Bleomycin—skin cancer	0.00351	0.00351	CcSEcCtD
Zanamivir—Diarrhoea—Vemurafenib—skin cancer	0.00348	0.00348	CcSEcCtD
Zanamivir—Erythema multiforme—Temozolomide—skin cancer	0.00346	0.00346	CcSEcCtD
Zanamivir—Urticaria—Imiquimod—skin cancer	0.00345	0.00345	CcSEcCtD
Zanamivir—Abdominal pain—Imiquimod—skin cancer	0.00343	0.00343	CcSEcCtD
Zanamivir—Body temperature increased—Imiquimod—skin cancer	0.00343	0.00343	CcSEcCtD
Zanamivir—Malaise—Bleomycin—skin cancer	0.00341	0.00341	CcSEcCtD
Zanamivir—Haemoglobin—Fluorouracil—skin cancer	0.00339	0.00339	CcSEcCtD
Zanamivir—Haemorrhage—Fluorouracil—skin cancer	0.00338	0.00338	CcSEcCtD
Zanamivir—Dizziness—Vemurafenib—skin cancer	0.00337	0.00337	CcSEcCtD
Zanamivir—Cough—Bleomycin—skin cancer	0.0033	0.0033	CcSEcCtD
Zanamivir—Chills—Temozolomide—skin cancer	0.00329	0.00329	CcSEcCtD
Zanamivir—Dehydration—Docetaxel—skin cancer	0.00328	0.00328	CcSEcCtD
Zanamivir—Ill-defined disorder—Dactinomycin—skin cancer	0.00327	0.00327	CcSEcCtD
Zanamivir—Vomiting—Vemurafenib—skin cancer	0.00324	0.00324	CcSEcCtD
Zanamivir—Myalgia—Bleomycin—skin cancer	0.00322	0.00322	CcSEcCtD
Zanamivir—Rash—Vemurafenib—skin cancer	0.00321	0.00321	CcSEcCtD
Zanamivir—Dermatitis—Vemurafenib—skin cancer	0.00321	0.00321	CcSEcCtD
Zanamivir—Hypersensitivity—Imiquimod—skin cancer	0.0032	0.0032	CcSEcCtD
Zanamivir—Headache—Vemurafenib—skin cancer	0.00319	0.00319	CcSEcCtD
Zanamivir—Discomfort—Bleomycin—skin cancer	0.00318	0.00318	CcSEcCtD
Zanamivir—Malaise—Dactinomycin—skin cancer	0.00318	0.00318	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.00317	0.00317	CcSEcCtD
Zanamivir—Asthenia—Imiquimod—skin cancer	0.00312	0.00312	CcSEcCtD
Zanamivir—Confusional state—Bleomycin—skin cancer	0.00311	0.00311	CcSEcCtD
Zanamivir—Anaphylactic shock—Bleomycin—skin cancer	0.00309	0.00309	CcSEcCtD
Zanamivir—Infection—Bleomycin—skin cancer	0.00307	0.00307	CcSEcCtD
Zanamivir—Nausea—Vemurafenib—skin cancer	0.00303	0.00303	CcSEcCtD
Zanamivir—Arrhythmia—Fluorouracil—skin cancer	0.00302	0.00302	CcSEcCtD
Zanamivir—Myalgia—Dactinomycin—skin cancer	0.003	0.003	CcSEcCtD
Zanamivir—Bronchospasm—Docetaxel—skin cancer	0.00299	0.00299	CcSEcCtD
Zanamivir—Diarrhoea—Imiquimod—skin cancer	0.00297	0.00297	CcSEcCtD
Zanamivir—Discomfort—Dactinomycin—skin cancer	0.00297	0.00297	CcSEcCtD
Zanamivir—Ill-defined disorder—Temozolomide—skin cancer	0.00296	0.00296	CcSEcCtD
Zanamivir—Anorexia—Bleomycin—skin cancer	0.00294	0.00294	CcSEcCtD
Zanamivir—Agitation—Temozolomide—skin cancer	0.00293	0.00293	CcSEcCtD
Zanamivir—Malaise—Temozolomide—skin cancer	0.00288	0.00288	CcSEcCtD
Zanamivir—Dizziness—Imiquimod—skin cancer	0.00287	0.00287	CcSEcCtD
Zanamivir—Infection—Dactinomycin—skin cancer	0.00286	0.00286	CcSEcCtD
Zanamivir—Neutropenia—Docetaxel—skin cancer	0.00285	0.00285	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00281	0.00281	CcSEcCtD
Zanamivir—Cough—Temozolomide—skin cancer	0.00278	0.00278	CcSEcCtD
Zanamivir—Convulsion—Temozolomide—skin cancer	0.00276	0.00276	CcSEcCtD
Zanamivir—Vomiting—Imiquimod—skin cancer	0.00276	0.00276	CcSEcCtD
Zanamivir—Dyspnoea—Bleomycin—skin cancer	0.00275	0.00275	CcSEcCtD
Zanamivir—Anorexia—Dactinomycin—skin cancer	0.00274	0.00274	CcSEcCtD
Zanamivir—Rash—Imiquimod—skin cancer	0.00274	0.00274	CcSEcCtD
Zanamivir—Dermatitis—Imiquimod—skin cancer	0.00274	0.00274	CcSEcCtD
Zanamivir—Headache—Imiquimod—skin cancer	0.00272	0.00272	CcSEcCtD
Zanamivir—Myalgia—Temozolomide—skin cancer	0.00272	0.00272	CcSEcCtD
Zanamivir—Arthralgia—Temozolomide—skin cancer	0.00272	0.00272	CcSEcCtD
Zanamivir—Anxiety—Temozolomide—skin cancer	0.00271	0.00271	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.0027	0.0027	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.00269	0.00269	CcSEcCtD
Zanamivir—Discomfort—Temozolomide—skin cancer	0.00268	0.00268	CcSEcCtD
Zanamivir—Decreased appetite—Bleomycin—skin cancer	0.00268	0.00268	CcSEcCtD
Zanamivir—Pain—Bleomycin—skin cancer	0.00264	0.00264	CcSEcCtD
Zanamivir—Confusional state—Temozolomide—skin cancer	0.00262	0.00262	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00262	0.00262	CcSEcCtD
Zanamivir—Anaphylactic shock—Temozolomide—skin cancer	0.0026	0.0026	CcSEcCtD
Zanamivir—Infection—Temozolomide—skin cancer	0.00259	0.00259	CcSEcCtD
Zanamivir—Nausea—Imiquimod—skin cancer	0.00258	0.00258	CcSEcCtD
Zanamivir—Convulsion—Fluorouracil—skin cancer	0.00255	0.00255	CcSEcCtD
Zanamivir—Feeling abnormal—Bleomycin—skin cancer	0.00254	0.00254	CcSEcCtD
Zanamivir—Skin disorder—Temozolomide—skin cancer	0.00253	0.00253	CcSEcCtD
Zanamivir—Myalgia—Fluorouracil—skin cancer	0.0025	0.0025	CcSEcCtD
Zanamivir—Decreased appetite—Dactinomycin—skin cancer	0.0025	0.0025	CcSEcCtD
Zanamivir—Fatigue—Dactinomycin—skin cancer	0.00248	0.00248	CcSEcCtD
Zanamivir—Anorexia—Temozolomide—skin cancer	0.00248	0.00248	CcSEcCtD
Zanamivir—Discomfort—Fluorouracil—skin cancer	0.00247	0.00247	CcSEcCtD
Zanamivir—Pain—Dactinomycin—skin cancer	0.00246	0.00246	CcSEcCtD
Zanamivir—Urticaria—Bleomycin—skin cancer	0.00245	0.00245	CcSEcCtD
Zanamivir—Haemoglobin—Docetaxel—skin cancer	0.00245	0.00245	CcSEcCtD
Zanamivir—Body temperature increased—Bleomycin—skin cancer	0.00244	0.00244	CcSEcCtD
Zanamivir—Haemorrhage—Docetaxel—skin cancer	0.00244	0.00244	CcSEcCtD
Zanamivir—Confusional state—Fluorouracil—skin cancer	0.00242	0.00242	CcSEcCtD
Zanamivir—Anaphylactic shock—Fluorouracil—skin cancer	0.0024	0.0024	CcSEcCtD
Zanamivir—Infection—Fluorouracil—skin cancer	0.00238	0.00238	CcSEcCtD
Zanamivir—Feeling abnormal—Dactinomycin—skin cancer	0.00237	0.00237	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00237	0.00237	CcSEcCtD
Zanamivir—Gastrointestinal pain—Dactinomycin—skin cancer	0.00235	0.00235	CcSEcCtD
Zanamivir—Dyspnoea—Temozolomide—skin cancer	0.00232	0.00232	CcSEcCtD
Zanamivir—Erythema multiforme—Docetaxel—skin cancer	0.0023	0.0023	CcSEcCtD
Zanamivir—Anorexia—Fluorouracil—skin cancer	0.00229	0.00229	CcSEcCtD
Zanamivir—Abdominal pain—Dactinomycin—skin cancer	0.00227	0.00227	CcSEcCtD
Zanamivir—Body temperature increased—Dactinomycin—skin cancer	0.00227	0.00227	CcSEcCtD
Zanamivir—Hypersensitivity—Bleomycin—skin cancer	0.00227	0.00227	CcSEcCtD
Zanamivir—Decreased appetite—Temozolomide—skin cancer	0.00226	0.00226	CcSEcCtD
Zanamivir—Fatigue—Temozolomide—skin cancer	0.00224	0.00224	CcSEcCtD
Zanamivir—Pain—Temozolomide—skin cancer	0.00223	0.00223	CcSEcCtD
Zanamivir—Asthenia—Bleomycin—skin cancer	0.00221	0.00221	CcSEcCtD
Zanamivir—Chills—Docetaxel—skin cancer	0.00219	0.00219	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00218	0.00218	CcSEcCtD
Zanamivir—Arrhythmia—Docetaxel—skin cancer	0.00218	0.00218	CcSEcCtD
Zanamivir—Feeling abnormal—Temozolomide—skin cancer	0.00214	0.00214	CcSEcCtD
Zanamivir—Dyspnoea—Fluorouracil—skin cancer	0.00214	0.00214	CcSEcCtD
Zanamivir—Gastrointestinal pain—Temozolomide—skin cancer	0.00213	0.00213	CcSEcCtD
Zanamivir—Hypersensitivity—Dactinomycin—skin cancer	0.00212	0.00212	CcSEcCtD
Zanamivir—Decreased appetite—Fluorouracil—skin cancer	0.00208	0.00208	CcSEcCtD
Zanamivir—Urticaria—Temozolomide—skin cancer	0.00207	0.00207	CcSEcCtD
Zanamivir—Asthenia—Dactinomycin—skin cancer	0.00206	0.00206	CcSEcCtD
Zanamivir—Body temperature increased—Temozolomide—skin cancer	0.00206	0.00206	CcSEcCtD
Zanamivir—Abdominal pain—Temozolomide—skin cancer	0.00206	0.00206	CcSEcCtD
Zanamivir—Pain—Fluorouracil—skin cancer	0.00205	0.00205	CcSEcCtD
Zanamivir—Feeling abnormal—Fluorouracil—skin cancer	0.00198	0.00198	CcSEcCtD
Zanamivir—Diarrhoea—Dactinomycin—skin cancer	0.00197	0.00197	CcSEcCtD
Zanamivir—Vomiting—Bleomycin—skin cancer	0.00196	0.00196	CcSEcCtD
Zanamivir—Rash—Bleomycin—skin cancer	0.00195	0.00195	CcSEcCtD
Zanamivir—Dermatitis—Bleomycin—skin cancer	0.00194	0.00194	CcSEcCtD
Zanamivir—Hypersensitivity—Temozolomide—skin cancer	0.00192	0.00192	CcSEcCtD
Zanamivir—Urticaria—Fluorouracil—skin cancer	0.00191	0.00191	CcSEcCtD
Zanamivir—Syncope—Docetaxel—skin cancer	0.0019	0.0019	CcSEcCtD
Zanamivir—Body temperature increased—Fluorouracil—skin cancer	0.0019	0.0019	CcSEcCtD
Zanamivir—Asthenia—Temozolomide—skin cancer	0.00187	0.00187	CcSEcCtD
Zanamivir—Loss of consciousness—Docetaxel—skin cancer	0.00186	0.00186	CcSEcCtD
Zanamivir—Cough—Docetaxel—skin cancer	0.00185	0.00185	CcSEcCtD
Zanamivir—Convulsion—Docetaxel—skin cancer	0.00184	0.00184	CcSEcCtD
Zanamivir—Nausea—Bleomycin—skin cancer	0.00183	0.00183	CcSEcCtD
Zanamivir—Vomiting—Dactinomycin—skin cancer	0.00183	0.00183	CcSEcCtD
Zanamivir—Rash—Dactinomycin—skin cancer	0.00181	0.00181	CcSEcCtD
Zanamivir—Myalgia—Docetaxel—skin cancer	0.00181	0.00181	CcSEcCtD
Zanamivir—Arthralgia—Docetaxel—skin cancer	0.00181	0.00181	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.00179	0.00179	CcSEcCtD
Zanamivir—Diarrhoea—Temozolomide—skin cancer	0.00178	0.00178	CcSEcCtD
Zanamivir—Hypersensitivity—Fluorouracil—skin cancer	0.00177	0.00177	CcSEcCtD
Zanamivir—Confusional state—Docetaxel—skin cancer	0.00175	0.00175	CcSEcCtD
Zanamivir—Anaphylactic shock—Docetaxel—skin cancer	0.00173	0.00173	CcSEcCtD
Zanamivir—Dizziness—Temozolomide—skin cancer	0.00172	0.00172	CcSEcCtD
Zanamivir—Infection—Docetaxel—skin cancer	0.00172	0.00172	CcSEcCtD
Zanamivir—Nausea—Dactinomycin—skin cancer	0.00171	0.00171	CcSEcCtD
Zanamivir—Shock—Docetaxel—skin cancer	0.0017	0.0017	CcSEcCtD
Zanamivir—Skin disorder—Docetaxel—skin cancer	0.00168	0.00168	CcSEcCtD
Zanamivir—Vomiting—Temozolomide—skin cancer	0.00165	0.00165	CcSEcCtD
Zanamivir—Anorexia—Docetaxel—skin cancer	0.00165	0.00165	CcSEcCtD
Zanamivir—Rash—Temozolomide—skin cancer	0.00164	0.00164	CcSEcCtD
Zanamivir—Diarrhoea—Fluorouracil—skin cancer	0.00164	0.00164	CcSEcCtD
Zanamivir—Dermatitis—Temozolomide—skin cancer	0.00164	0.00164	CcSEcCtD
Zanamivir—Headache—Temozolomide—skin cancer	0.00163	0.00163	CcSEcCtD
Zanamivir—Dizziness—Fluorouracil—skin cancer	0.00159	0.00159	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Docetaxel—skin cancer	0.00158	0.00158	CcSEcCtD
Zanamivir—Nausea—Temozolomide—skin cancer	0.00155	0.00155	CcSEcCtD
Zanamivir—Dyspnoea—Docetaxel—skin cancer	0.00154	0.00154	CcSEcCtD
Zanamivir—Vomiting—Fluorouracil—skin cancer	0.00152	0.00152	CcSEcCtD
Zanamivir—Rash—Fluorouracil—skin cancer	0.00151	0.00151	CcSEcCtD
Zanamivir—Dermatitis—Fluorouracil—skin cancer	0.00151	0.00151	CcSEcCtD
Zanamivir—Decreased appetite—Docetaxel—skin cancer	0.0015	0.0015	CcSEcCtD
Zanamivir—Headache—Fluorouracil—skin cancer	0.0015	0.0015	CcSEcCtD
Zanamivir—Fatigue—Docetaxel—skin cancer	0.00149	0.00149	CcSEcCtD
Zanamivir—Pain—Docetaxel—skin cancer	0.00148	0.00148	CcSEcCtD
Zanamivir—Feeling abnormal—Docetaxel—skin cancer	0.00143	0.00143	CcSEcCtD
Zanamivir—Nausea—Fluorouracil—skin cancer	0.00142	0.00142	CcSEcCtD
Zanamivir—Gastrointestinal pain—Docetaxel—skin cancer	0.00142	0.00142	CcSEcCtD
Zanamivir—Abdominal pain—Docetaxel—skin cancer	0.00137	0.00137	CcSEcCtD
Zanamivir—Body temperature increased—Docetaxel—skin cancer	0.00137	0.00137	CcSEcCtD
Zanamivir—Hypersensitivity—Docetaxel—skin cancer	0.00128	0.00128	CcSEcCtD
Zanamivir—Asthenia—Docetaxel—skin cancer	0.00124	0.00124	CcSEcCtD
Zanamivir—Diarrhoea—Docetaxel—skin cancer	0.00118	0.00118	CcSEcCtD
Zanamivir—Dizziness—Docetaxel—skin cancer	0.00114	0.00114	CcSEcCtD
Zanamivir—Vomiting—Docetaxel—skin cancer	0.0011	0.0011	CcSEcCtD
Zanamivir—Rash—Docetaxel—skin cancer	0.00109	0.00109	CcSEcCtD
Zanamivir—Dermatitis—Docetaxel—skin cancer	0.00109	0.00109	CcSEcCtD
Zanamivir—Headache—Docetaxel—skin cancer	0.00108	0.00108	CcSEcCtD
Zanamivir—Nausea—Docetaxel—skin cancer	0.00103	0.00103	CcSEcCtD
